Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J P Bilezikian
Reduced Lymphocyte Stimulatory Guanine Nucleotide Regulatory Protein and Beta-Adrenergic Receptors in Congestive Heart Failure and Reversal With Angiotensin Converting Enzyme Inhibitor Therapy
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Developmental Changes in the Electrophysiological Properties and the Beta-Adrenergic Receptor-Effector Complex in Atrial Fibers of the Canine Coronary Sinus
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Differential Actions of Vasopeptidase Inhibition Versus Angiotensin-Converting Enzyme Inhibition on Diuretic Therapy in Experimental Congestive Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Acute and Long-Term Response to an Oral Converting-Enzyme Inhibitor, Captopril, in Congestive Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Effect of Different Angiotensin-Converting-Enzyme Inhibitors on Mortality Among Elderly Patients With Congestive Heart Failure
CMAJ
Medicine
Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure
Journal of Cardiovascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Angiotensin Converting Enzyme (ACE) Inhibitor
Journal of Nihon University Medical Association
Up-Titrating Angiotensin-Converting Enzyme Inhibitors in Heart Failure: Evidence and Challenges
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Temporal Patterns in the Medical Treatment of Congestive Heart Failure With Angiotensin-Converting Enzyme Inhibitors in Older Adults, 1989 Through 1995
Archives of Internal Medicine
Hormonal and Renal Differences Between Low Dose and High Dose Angiotensin Converting Enzyme Inhibitor Treatment in Patients With Chronic Heart Failure.
Heart
Cardiovascular Medicine
Cardiology
Pcv104 - Beta-Blockers, Angiotensin Ii, and Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure. Differences in Prescription by Gender, Socioeconomic Status and Comorbidity After a First Hospitalization for Heart Failure
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental